Thomas J Kester
CIK 1299870 · last filed 2025-09-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NSPR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
321 COLUMBUS AVENUE
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NSPR | Director | 458,573 | $0.45 | $206.4K | $175.0K | 12 | 2025-09-17 |
| InspireMD, Inc. (NSPRZ) Delisted | Director | 39,355 | $0.01 | $354 | $0 | 1 | 2021-10-14 |
| InspireMD, Inc. (NSPR.WS.B) Delisted | Director | 331,593 | $0.03 | $9.9K | $95.7K | 5 | 2021-02-10 |
| InspireMD, Inc. (NSPR.WS) Delisted | Director | — | $0.05 | — | $0 | 2 | 2016-12-08 |
| OFIX | Director | 7,328 | $9.78 | $71.7K | $113.6K | 6 | 2010-12-17 |
Recent Filings · Page 2 of 3
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-16 | NSPR | Buy (P) | +61,249 | $100.0K | EDGAR |
| 2023-04-04 | NSPR | Grant (A) | +7,986 | $0 | EDGAR |
| 2021-10-14 | InspireMD, Inc. (NSPRZ) Delisted | Grant (A) | +17,248 | $0 | EDGAR |
| 2021-02-10 | InspireMD, Inc. (NSPR.WS.B) Delisted | Buy (P) | +120,960 | $75.0K | EDGAR |
| 2020-09-02 | InspireMD, Inc. (NSPR.WS.B) Delisted | Grant (A) | +158,033 | $0 | EDGAR |
| 2020-06-05 | InspireMD, Inc. (NSPR.WS.B) Delisted | Buy (P) | +50,000 | $20.8K | EDGAR |
| 2019-02-06 | InspireMD, Inc. (NSPR.WS.B) Delisted | Grant (A) | +130,000 | $0 | EDGAR |
| 2018-11-26 | InspireMD, Inc. (NSPR.WS.B) Delisted | Sell (S) | −8 | -$2 | EDGAR |
| 2016-12-08 | InspireMD, Inc. (NSPR.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-09-08 | InspireMD, Inc. (NSPR.WS) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.